You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 148 No. 12, December 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effects of Antihypertensive Agents on Circadian Blood Pressure and Heart Rate Patterns

Review

Mark A. Sirgo, PharmD; Rose J. Mills, MPH; Vincent DeQuattro, MD

Arch Intern Med. 1988;148(12):2547-2552.


Abstract

• Blood pressure and heart rate exhibit a circadian rhythm, with both rising rapidly during the morning hours and then decreasing throughout the day to a nadir around 3 AM. Current evidence suggests a possible link between cardiovascular events, such as myocardial infarction and sudden cardiac death, which have been shown to occur most frequently during the morning hours, and the rapid rise in blood pressure and heart rate during this same time period. We review data from ambulatory blood pressure studies to ascertain which antihypertensive agents provide the most satisfactory control of blood pressure and heart rate during the hours of 6 AM to 12 noon. Of the forms of drug therapy studied, labetalol, a combined {alpha}- and β-blocker, and two calcium channel blockers, nifedipine and verapamil, appear to be the most effective in blunting the rise in arterial blood pressure during these critical morning hours.

(Arch Intern Med 1988;148:2547-2552)



Author Affiliations

From New Product Development, Glaxo Inc, Research Triangle Park, NC (Dr Sirgo and Ms Mills) and Hypertension Service, Los Angeles County-University of Southern California Medical Center, Los Angeles (Dr DeQuattro).


Footnotes

Accepted for publication July 13, 1988.

Reprint requests to Glaxo Inc, Research Triangle Park, NC 27709 (Dr Sirgo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chronobiological aspects of antihypertensive treatment with calcium antagonists
Koch and Raschka
Eur Heart J 2000;21:1555-1555.
 

National High Blood Pressure Education Program Working Group Report on Ambulatory Blood Pressure Monitoring
The National High Blood Pressure Education Program
Arch Intern Med 1990;150:2270-2280.
ABSTRACT  

Treatment of Isolated Systolic Hypertension With Labetalol in the Elderly
Giles et al.
Arch Intern Med 1990;150:974-976.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.